isoxazoles has been researched along with Carcinoma, Ehrlich Tumor in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anil, SM; Balaji, KS; Jayarama, S; Kiran, KR; Lingaraju, GS; Sadashiva, MP | 1 |
| Balaji, KS; Jagadish, S; Jayarama, S; Mohan, CD; Rakesh, KS; Rangappa, KS; Swaroop, TR; Zameer, F | 1 |
| Ali, EA; Bahr, HI; Mohammad, HM; Mohammed, EA; Toraih, EA; Zaitone, SA | 1 |
| Hamama, WS; Ibrahim, ME; Zoorob, HH | 1 |
| Maity, P; Roy, S | 1 |
| Bashford, CL; Pasternak, CA | 1 |
| Holcenberg, JS | 1 |
| Eddy, AA | 1 |
1 review(s) available for isoxazoles and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Sodium cotransport systems and the membrane potential difference.
Topics: Adenosine Triphosphate; Amino Acids; Animals; Biological Transport, Active; Carcinoma, Ehrlich Tumor; Carrier Proteins; Cell Membrane; Electrochemistry; Energy Metabolism; Fluorescent Dyes; Humans; Indicators and Reagents; Ion Channels; Ionophores; Isoxazoles; Kinetics; Membrane Potentials; Mice; Models, Biological; Nigericin; Sodium | 1985 |
7 other study(ies) available for isoxazoles and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Synthesis of new coumarin tethered isoxazolines as potential anticancer agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coumarins; Disease Models, Animal; Humans; Isoxazoles; Microvessels; Structure-Activity Relationship; Survival Rate | 2018 |
3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Binding Sites; Carcinoma, Ehrlich Tumor; Catalytic Domain; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; HeLa Cells; Humans; Inflammation; Isoxazoles; Lipoxygenase; Lipoxygenase Inhibitors; Mice; Molecular Docking Simulation; Thiophenes | 2016 |
Chemopreventive effect of leflunomide against Ehrlich's solid tumor grown in mice: Effect on EGF and EGFR expression and tumor proliferation.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Profiling; Immunohistochemistry; Isoxazoles; Leflunomide; Mice; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Tumor Necrosis Factor-alpha | 2015 |
Efficient regioselective synthesis and potential antitumor evaluation of isoxazolo[5,4-b]pyridines and related annulated compounds.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cyclization; Drug Screening Assays, Antitumor; Isoxazoles; Pyridines | 2012 |
Effect of glutamine analogue-acivicin on tumor induced angiogenesis in Ehrlich ascites carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Ehrlich Tumor; Isoxazoles; Male; Mice; Neovascularization, Pathologic | 2005 |
Plasma membrane potential of Lettré cells does not depend on cation gradients but on pumps.
Topics: Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carcinoma, Ehrlich Tumor; Cations; Cell Membrane; Fluorescent Dyes; Isoxazoles; Kinetics; Membrane Potentials; Mice; Models, Biological; Ouabain; Thermodynamics; Valinomycin | 1984 |
Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
Topics: Acinetobacter; Amino Acids; Animals; Asparaginase; Carcinoma, Ehrlich Tumor; Drug Synergism; Drug Therapy, Combination; Female; Glutaminase; Glutamine; Glycine; Isoxazoles; Lethal Dose 50; Leukemia L1210; Male; Mice; Oxazoles | 1979 |